Breaking News Instant updates and real-time market news.

RIGL

Rigel Pharmaceuticals

$3.33

0.11 (3.42%)

06:55
04/09/18
04/09
06:55
04/09/18
06:55

Rigel Pharmaceuticals shares can rally 80% on FDA approval, says JPMorgan

JPMorgan analyst Anupam Rama continues to see a favorable risk/reward profile on Rigel Pharmaceuticals heading into the April 17 FDA action date for Tavalisse in immune thrombocytopenia. The analyst sees a "high probability" of approval for Tavalisse and 50%-80% share upside on the news, "assuming no major surprises in the label." The approval is setting up to be a "true binary event," with potential share downside in the 65%-80% range, Rama tells investors in a research note. He keeps an Overweight rating on Rigel shares.

  • 17

    Apr

RIGL Rigel Pharmaceuticals
$3.33

0.11 (3.42%)

04/03/18
PIPR
04/03/18
NO CHANGE
PIPR
Piper remains buyer of Rigel despite IgAN trial missing primary endpoint
Piper Jaffray analyst Christopher Raymond kept an Overweight rating on Rigel Pharmaceuticals despite the company's disclosure that its Phase 2 trial evaluating fostamatinib in IgAN failed to meet its primary endpoint. Raymond did not factor the IgAN nephropathy in his model, and this event did not change his positive view into the fostamatinib ITP PDUFA on April 17.
04/03/18
JEFF
04/03/18
NO CHANGE
Target $5
JEFF
Buy
Rigel selloff on IgAN trial miss overdone, says Jefferies
Jefferies analyst Eun Yang called the fact that Rigel Pharmaceuticals' Phase 2 trial evaluating fostamatinib in IgAN failed to meet its primary endpoint "somewhat disappointing," but also said the news does not change his valuation or view on the approvability in patients with chronic or persistent immune thrombocytopenia. The analyst, who said the company is "completely optimistic" for timely approval of fostamatinib in the ITP indication by the PDUFA date of April 17, keeps a Buy rating and $5 price target on Rigel shares, calling today's selloff "overdone."
04/03/18
HCWC
04/03/18
NO CHANGE
Target $6.7
HCWC
Buy
H.C. Wainwright says Rigel's 'small setback' a buying opportunity ahead of PDUFA
H.C. Wainwright analyst Joseph Pantginis called news that Rigel Pharmaceuticals' Phase 2 study of fostamatinib in patients with IgA nephropathy did not meet its primary endpoint a "small setback" for the company and an opportunity for investors. He believes today's selling pressure is an overreaction, adding that "brighter skies may be tomorrow, almost literally," with the company's PDUFA date for fostamatinib in ITP coming on April 17. Pantginis reiterates a Buy rating on Rigel and trimmed his price target on the stock to $6.70 from $7.
04/04/18
JEFF
04/04/18
NO CHANGE
Target $5
JEFF
Buy
Rigel selloff yesterday on failed study overdone, says Jefferies
Jefferies analyst Eun Yang says that while yesterday's Phase 2 trial results in IgA nephropathy, fostamatinib's third indication, is "somewhat disappointing," it does not change her valuation or upcoming approvability in first indication immune thrombocytopenic purpura. The analyst views the selloff yesterday in shares of Rigel Pharmaceuticals as overdone. She believes the failed study has no bearing on the approval in ITP, which has an FDA action date of April 17. Yang reiterates a Buy rating on Rigel with a $5 price target.

TODAY'S FREE FLY STORIES

TPIC

TPI Composites

$26.15

-0.09 (-0.34%)

08:48
08/15/18
08/15
08:48
08/15/18
08:48
Conference/Events
TPI Composites management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

  • 04

    Oct

SYF

Synchrony

$30.01

0.81 (2.77%)

08:47
08/15/18
08/15
08:47
08/15/18
08:47
Hot Stocks
Synchrony reports July charge off rate 5.01% vs. 4.73% last month »

Reports July 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$50.17

-0.11 (-0.22%)

, ZTCOY

ZTE Corp.

$0.00

(0.00%)

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Recommendations
Cree, ZTE Corp. analyst commentary  »

Cree organic growth above…

CREE

Cree

$50.17

-0.11 (-0.22%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

DRYS

DryShips

$4.60

-0.05 (-1.08%)

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Hot Stocks
DryShips announces sale of Panamax drybulk carrier »

DryShips announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Conference/Events
The Washington Journal holds a discussion on NAFTA renegotiations & trade policy »

Public Citizen Global…

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
U.S. retail sales rose 0.5% in July, with the ex-auto component up 0.6% »

U.S. retail sales rose…

HMNY

Helios and Matheson

$0.05

0.0001 (0.20%)

, ASHR

X-trackers Harvest CSI 300

$24.87

(0.00%)

08:45
08/15/18
08/15
08:45
08/15/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

HMNY

Helios and Matheson

$0.05

0.0001 (0.20%)

ASHR

X-trackers Harvest CSI 300

$24.87

(0.00%)

JNK

SPDR Barclays High Yield Bond

$35.86

0.065 (0.18%)

IRBT

iRobot

$87.83

1.72 (2.00%)

ENB

Enbridge

$35.51

0.3108 (0.88%)

WLL

Whiting Petroleum

$48.18

1.73 (3.72%)

HEAR

Turtle Beach

$26.80

-1.15 (-4.11%)

AMJ

American Medical Laboratories Inc

$29.11

0.2 (0.69%)

UCO

Universal Compression

$29.37

-0.06 (-0.20%)

GOGO

Gogo

$4.42

0.05 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 04

    Sep

  • 05

    Sep

  • 06

    Sep

  • 13

    Sep

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
FX Action: The dollar »

FX Action: The dollar…

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
U.S. Empire State manufacturing index bounced 3 points to 25.6 in August »

U.S. Empire State…

08:42
08/15/18
08/15
08:42
08/15/18
08:42
Conference/Events
RBC Capital to hold a conference »

Consumer Investor Day…

08:41
08/15/18
08/15
08:41
08/15/18
08:41
Conference/Events
Stephens to hold a field trip »

Building Products…

BKH

Black Hills

$60.23

0.235 (0.39%)

, GGG

Graco

$46.02

0.025 (0.05%)

08:40
08/15/18
08/15
08:40
08/15/18
08:40
Conference/Events
CFA Society of Minnesota to hold a conference »

7th Annual Investor…

BKH

Black Hills

$60.23

0.235 (0.39%)

GGG

Graco

$46.02

0.025 (0.05%)

CLFD

Clearfield

$13.05

0.35 (2.76%)

CYBE

Cyberoptics

$19.25

0.05 (0.26%)

CHRW

C.H. Robinson

$93.98

0.02 (0.02%)

DAKT

Daktronics

$8.43

0.02 (0.24%)

CBZ

CBIZ

$22.93

0.275 (1.21%)

DGII

Digi International

$12.95

-0.025 (-0.19%)

PII

Polaris Industries

$107.72

0.42 (0.39%)

ASV

ASV Holdings

$6.28

-0.27 (-4.12%)

ALE

Allete

$77.99

0.97 (1.26%)

DOC

Physicians Realty Trust

$16.83

0.22 (1.32%)

APOG

Apogee Enterprises

$49.74

0.55 (1.12%)

MOS

Mosaic

$30.63

0.25 (0.82%)

DCI

Donaldson

$47.69

0.88 (1.88%)

SRDX

Surmodics

$73.05

2.1 (2.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 26

    Aug

  • 06

    Sep

  • 06

    Sep

  • 29

    Oct

  • 06

    Nov

SHLX

Shell Midstream

$22.73

0.35 (1.56%)

08:39
08/15/18
08/15
08:39
08/15/18
08:39
Hot Stocks
Shell Midstream joint venture Zydeco announces binding open season »

Zydeco, jointly owned by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

08:37
08/15/18
08/15
08:37
08/15/18
08:37
Hot Stocks
Breaking Hot Stocks news story on KMG Chemicals »

KMG Chemicals trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$129.47

-0.67 (-0.51%)

08:36
08/15/18
08/15
08:36
08/15/18
08:36
Recommendations
Lululemon analyst commentary  »

Lululemon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

IDXG

Interpace Diagnostics

$1.03

-0.01 (-0.96%)

08:36
08/15/18
08/15
08:36
08/15/18
08:36
Hot Stocks
Interpace Diagnostics acquires assets of Rosetta Genomics out of bankruptcy »

Interpace Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$193.08

-1.03 (-0.53%)

08:34
08/15/18
08/15
08:34
08/15/18
08:34
Recommendations
Home Depot analyst commentary  »

Stifel sees 'no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$1.03

(0.00%)

08:33
08/15/18
08/15
08:33
08/15/18
08:33
Hot Stocks
CEL-SCI says IDMC recommends continuation of Phase 3 head and neck cancer study »

CEL-SCI announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:33
08/15/18
08/15
08:33
08/15/18
08:33
General news
Empire State Mfg Survey General Business Conditions Index data reported »

August Empire State Mfg…

CE

Celanese

$116.73

0.7 (0.60%)

08:32
08/15/18
08/15
08:32
08/15/18
08:32
Hot Stocks
Celanese granted four new patents for Sunett sweetner »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CYTX

Cytori Therapeutics

$0.40

0.015 (3.95%)

08:32
08/15/18
08/15
08:32
08/15/18
08:32
Downgrade
Cytori Therapeutics rating change  »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

, CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

08:31
08/15/18
08/15
08:31
08/15/18
08:31
Conference/Events
Cabot Microelectronics to hold a conference call »

Conference call to…

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

TPR

Tapestry

$53.12

5.7 (12.02%)

08:31
08/15/18
08/15
08:31
08/15/18
08:31
Recommendations
Tapestry analyst commentary  »

Tapestry price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

, KMG

KMG Chemicals

$66.78

0.1 (0.15%)

08:30
08/15/18
08/15
08:30
08/15/18
08:30
Hot Stocks
Cabot Microelectronics to acquire KMG Chemicals for $1.6B »

Cabot Microelectronics…

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

ASRT

Assertio Therapeutics

$7.31

0.135 (1.88%)

, JNP

Juniper Pharmaceuticals

$11.50

(0.00%)

08:30
08/15/18
08/15
08:30
08/15/18
08:30
Options
One new option listing and three option delistings on August 15th »

New option listings for…

ASRT

Assertio Therapeutics

$7.31

0.135 (1.88%)

JNP

Juniper Pharmaceuticals

$11.50

(0.00%)

XPLR

Xplore Technologies

$5.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.